معرفی
Huabing Li is an Assistant Professor at the Shanghai Jiao Tong University School of Medicine, leading a lab focused on RNA epigenetic modifications and their roles in immune cells and diseases. He holds a B.S. and M.S. from Nankai University, and a Ph.D. in Biochemistry from Rutgers University, followed by postdoctoral training at Yale University School of Medicine. His research explores RNA modifications (e.g., m6A, acetylation) in T cell function, autoimmune diseases, and cancer immunology, using mouse models and advanced technologies.
Education:
- B.S., Nankai University (2002)
- M.S., Nankai University (2005)
- Ph.D., Biochemistry, Rutgers University (2011)
Research Interests: Dr. Li’s work centers on RNA epigenetic switches, including how modifications like m6A and acetylation regulate immune responses, T cell pathogenicity, and tumor immunity. His lab investigates mechanisms underlying inflammatory bowel disease, autoimmune disorders, and cancer, aiming to identify therapeutic targets. Key areas include:
- RNA modification enzymes (e.g., METTL3, NAT10)
- Immune cell signaling and activation
- Mouse models of inflammation and autoimmunity
Publications: His recent work highlights roles of RNA modifications in T cell function, macrophage activation, and tumor immune evasion. Themes include epigenetic regulation of immune pathways, cross-talk between RNA modifiers, and translational applications in drug development.
Awards/Grants: No specific awards listed, though his lab’s international collaborations suggest competitive grant support.
Lab & Teams: The Li Lab collaborates with global institutions and utilizes cutting-edge tools like CRISPR screening and single-cell profiling. Their goal is to bridge basic research and clinical applications in immunology and oncology.
